title: Cholesterol Levels Should Play a More Important Role in Identifying Statin Recipients.
authors.affiliation: From Cardiovascular Research Group, School of Biomedicine, University of Manchester, UK (P.N.D.); and Cardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, UK (H.S.). pdurrington@manchester.ac.uk.
authors.forename: Paul N
authors.initials: PN
authors.lastname: Durrington
authors.affiliation: From Cardiovascular Research Group, School of Biomedicine, University of Manchester, UK (P.N.D.); and Cardiovascular Trials Unit, University Department of Medicine, Central Manchester University Hospitals NHS Foundation Trust, UK (H.S.).
authors.forename: Handrean
authors.initials: H
authors.lastname: Soran
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: atherosclerosis; cardiovascular events; cholesterol; primary prevention; statin therapy